North Capital’s Idexx Laboratories IDXX Stock Holding History

North Capital’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-13	Closed	-$8.31K	–	373
2025 Q3	$8.31K	Buy	13 +1	+8%	+$607	0.01%	401
2025 Q2	$6.44K	Hold	12	–	–	0.01%	421
2025 Q1	$5.04K	Buy	+12	New	+$5.21K	﹤0.01%	430

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

North Capital's IDXX Position: Q4 2025 in Review

North Capital sold out of Idexx Laboratories (IDXX) in Q4 2025, closing a stake of 13 shares — an estimated $8.31K sold.

North Capital first reported a position in IDXX in Q1 2025 and held it in 3 quarters. The position peaked at $8.31K in Q3 2025. 1,386 funds tracked by Wall St. Rank hold IDXX as of Q4 2025.

North Capital reported no remaining Idexx Laboratories position as of Q4 2025 after selling out during the quarter.
North Capital sold 13 Idexx Laboratories shares in Q4 2025, an estimated $8.31K.
North Capital first reported a position in Idexx Laboratories in Q1 2025 and held it in 3 quarters.
North Capital's Idexx Laboratories position peaked at $8.31K in Q3 2025.
1,386 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2025.

Based on North Capital's 13F filing for Q4 2025, filed 18 Feb 2026.